| Crystal structure of MST3-MO25 complex with WIF motif | |
Heteromer
Q9Y376; | 30-340 | 99.64 | 1×ADP; 1×MN; |
|
| Human MST3 (STK24) in complex with MO25beta | |
Heteromer
Q9H9S4; | 32-301 | 100.0 | 2×SO4; |
|
| Human MST3 (STK24) kinase in complex with inhibitor MR24 | | homo-2-mer | 26-301 | 100.0 | 2×VYN; 3×EDO; |
|
| Human MST3 kinase | | monomer | 18-310 | 66.67 | |
|
| MST3 in complex with CP-673451 | | monomer | 18-310 | 66.67 | 1×34U; 1×EDO; 1×PEG; |
|
| Human MST3 kinase in complex with ATP | | monomer | 18-310 | 66.67 | 1×ATP; |
|
| MST3 IN COMPLEX WITH CDK1/2 INHIBITOR III, 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUO… | | monomer | 18-310 | 66.67 | 1×EDO; 1×DKI; |
|
| Human MST3 kinase | | monomer | 18-310 | 66.67 | |
|
| MST3 IN COMPLEX WITH AT-9283, 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZ… | | monomer | 18-309 | 66.67 | 1×35R; 2×ACT; 2×EDO; 1×CL; |
|
| MST3 IN COMPLEX WITH Imidazolo-oxindole PKR inhibitor C16 | | monomer | 18-309 | 66.67 | 1×EDO; 1×34L; 1×PG4; 1×DMS; 1×CL; |
|
| MST3 IN COMPLEX WITH PF-03814735, N-{2-[(1S,4R)-6-{[4-(CYCLOBUTYLAMINO)-5-(TRIFLUOROMETHYL)PYRIMIDI… | | monomer | 19-310 | 100 | 1×34W; 2×EDO; |
|
| MST3 IN COMPLEX WITH STAUROSPORINE | | monomer | 20-310 | 100 | 1×STU; 1×CL; 1×EDO; |
|
| Structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06645342) | | monomer | 24-311 | 99.31 | 1×3JB; |
|
| MST3 in complex with SARACATINIB | | monomer | 24-311 | 99.31 | 1×H8H; |
|
| Human MST3 kinase in complex with adenine | | monomer | 25-311 | 99.3 | 1×ADE; |
|
| Human MST3 kinase in complex with MnADP | | monomer | 25-311 | 99.3 | 1×ADP; 2×MN; |
|
| MST3 IN COMPLEX WITH JNJ-7706621, 4-({5-AMINO-1-[(2,6-DIFLUOROPHENYL)CARBONYL]-1H-1,2,4-TRIAZOL-3-Y… | | monomer | 24-310 | 99.3 | 1×SKE; 1×MG; 1×DMS; |
|
| MST3 IN COMPLEX WITH PP-121, 1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRI… | | monomer | 24-310 | 99.3 | 1×KS1; 1×EDO; 1×ACT; |
|
| Crystal structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06447475) | | monomer | 24-310 | 99.3 | 1×MN; 1×3FE; |
|
| Crystal structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06454589). | | monomer | 24-310 | 99.3 | 1×3JA; |
|
| MST3 IN COMPLEX WITH SUNITINIB | | monomer | 25-311 | 99.3 | 1×B49; 2×CL; |
|
| MST3 in complex with HESPERADIN | | monomer | 27-311 | 100 | 1×H1N; 1×EDO; |
|
| MST3 IN COMPLEX WITH 2-(4,6-Diamino-1,3,5-triazin-2-yl)phenol | | monomer | 27-311 | 100 | 1×X11; |
|
| MST3 in complex with DASATINIB | | monomer | 27-310 | 100 | 1×1N1; 1×EDO; 1×CL; |
|
| MST3 in complex with BOSUTINIB | | monomer | 27-310 | 100 | 1×DB8; |
|
| MST3 in complex with AMP-PNP | | monomer | 30-310 | 100 | 1×EDO; 1×MG; 1×ANP; |
|
| MST3 IN COMPLEX WITH Danusertib | | monomer | 30-310 | 100 | 1×PGE; 1×EDO; 1×CL; 1×627; |
|
| Crystal structure of sterile 20-like kinase 3 (MST3, STK24) | | monomer | 32-310 | 100.0 | 2×HG; |
|
| Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine | | monomer | 32-310 | 100.0 | 1×STU; |
|
| Human MST3 (STK24) kinase in complex with inhibitor MR30 | | monomer | 25-301 | 100.0 | 1×VZ2; 3×EDO; |
|
| Human MST3 (STK24) kinase in complex with inhibitor MR26 | | monomer | 26-301 | 100.0 | 1×VYH; 11×EDO; |
|
| Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310 | | monomer | 26-301 | 100.0 | 1×VY0; 1×EDO; |
|
| Human MST3 (STK24) kinase in complex with inhibitor MR39 | | monomer | 26-301 | 100.0 | 1×SJL; 3×EDO; |
|
| MST3 in complex with MRIA7 | | monomer | 26-301 | 100.0 | 1×SQQ; |
|
| MST3 in complex with compound MRIA9 | | monomer | 26-301 | 100.0 | 1×SQ8; |
|
| MST3 in complex with MRIA11 | | monomer | 26-301 | 100.0 | 4×EDO; 1×SQE; |
|
| MST3 in complex with compound MRIA12 | | monomer | 26-301 | 100.0 | 7×EDO; 1×SQK; |
|
| MST3 in complex with compound G-5555 | | monomer | 26-301 | 100.0 | 1×59T; |
|
| MST3 in complex with compound MRIA13 | | monomer | 26-301 | 100.0 | 1×SQB; |
|
| Human MST3 (STK24) kinase in complex with inhibitor MRLW5 | | monomer | 26-301 | 100.0 | 1×SJX; |
|